Search

Your search keyword '"Schut, Erik"' showing total 334 results
Start Over Author "Schut, Erik"
334 results on '"Schut, Erik"'

109. Channeling consumers to preferred providers and the impact of status-quo bias: does type of provider matter?

Author

Boonen, LHHM (Lieke), Donkers, Bas, Schut, Erik, Health Systems and Insurance (HSI), and Business Economics

Abstract

Keywords:Managed competition;preferred provider choice;consumer channeling;status quo bias;discrete choice experiments Context. To effectively bargain about the price and quality of health services, health insurers need to successfully channel their enrollees. Little is known about consumer sensitivity to different channeling incentives. In particular, the impact of status quo bias, which is expected to differ between different provider types, can play a large role in insurers' channeling ability. Objective. To examine consumer sensitivity to channeling strategies and to analyze the impact of status quo bias for different provider types. Data Sources/Study Design. With a large-scale discrete choice experiment, we investigate the impact of channeling incentives on choices for pharmacies and general practitioners (GPs). Survey data were obtained among a representative Dutch household panel (n=2,500). Principal Findings. Negative financial incentives have a two to three times larger impact on provider choice than positive ones. Positive financial incentives have a relatively small impact on GP choice, while the impact of qualitative incentives is relatively large. Status quo bias has a large impact on provider choice, which is more prominent in the case of GPs than in the case of pharmacies. Conclusion. The large impact of the status quo bias makes channeling consumers away from their current providers a daunting task, particularly in the case of GPs.

Published
2011

119. Pharmaceutical policy in the Netherlands: From price regulation towards managed competition

Author

Boonen, LHHM (Lieke), van der Geest, Stephanie, Schut, Erik, Varkevisser, Marco, Dor, Avi, and Health Systems and Insurance (HSI)

Subjects
Government, Public economics, business.industry, Control (management), Pharmacy, Managed Competition, Momentum (finance), SDG 3 - Good Health and Well-being, Generic drug, Economics, Medical prescription, business, health care economics and organizations, Pharmaceutical policy
Abstract

Purpose - To analyse the development of pharmaceutical policy in the Dutch market for outpatient prescription drugs since the early 1990s. Methodology - A literature review and document analysis is performed to examine the effects of pharmaceutical policy on the performance of the Dutch market for outpatient prescription drugs since the early 1990s. Findings - Government efforts to control prices of pharmaceuticals were effective in constraining prices of in-patent drugs, but had an opposite effect on the prices of generic drugs. The gradual transition towards managed competition - that particularly gained momentum after the introduction of the new universal health insurance scheme in 2006 - appears to be more effective in constraining prices of generic drugs than earlier government efforts to control these prices. Originality - Comparative analysis of the impact of price regulation and managed competition on generic drug prices in the Netherlands. Implications - Implications of the changing role of health insurers are discussed for the future market for prescription drugs and role of pharmacies in the Netherlands.

Published
2010

126. Fusietoetsing in de zorg

Author

Varkevisser, Marco, Schut, Erik, and Health Systems and Insurance (HSI)

Published
2010

148. Opleiden medisch specialisten moet transparanter

Author

Varkevisser, Marco, van der Geest, Stephanie, Maasland, Emiel, Schut, Erik, Erasmus School of Health Policy & Management, Economics, and Health Systems and Insurance (HSI)

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results